Deoxythymidine-5'-triphosphate-15N2,d15 (dilithium)

CAT:
804-HY-138615S3
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Deoxythymidine-5'-triphosphate-15N2,d15 (dilithium) - image 1

Deoxythymidine-5'-triphosphate-15N2,d15 (dilithium)

  • UNSPSC Description:

    Deoxythymidine-5'-triphosphate-15N2,d15 (dTTP-15N2,d15) dilithium is deuterium and 15N labeled Deoxythymidine-5'-triphosphate (HY-138615). Deoxythymidine-5'-triphosphate (dTTP) is one of the four nucleoside triphosphates. Deoxythymidine-5'-triphosphate (dTTP) is used in the synthesis of DNA.
  • Target Antigen:

    DNA/RNA Synthesis; Endogenous Metabolite; Isotope-Labeled Compounds; Nucleoside Antimetabolite/Analog
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Cell Cycle/DNA Damage;Metabolic Enzyme/Protease;Others
  • Applications:

    COVID-19-anti-virus
  • Field of Research:

    Cancer; Infection
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O=C([15N]1[C@@]2([2H])C([2H])([2H])[C@@](O[2H])([2H])[C@](C([2H])([2H])OP(O[2H])(OP(OP(O[2H])(O[Li])=O)(O[Li])=O)=O)([2H])O2)[15N]([2H])C(C(C([2H])([2H])[2H])=C1[2H])=O
  • Molecular Weight:

    511.11
  • References & Citations:

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Tattersall MH, et al. Deoxyribonucleoside triphosphates in human cells: changes in disease and following exposure to drugs. Eur J Clin Invest. 1975;5(2):191-202.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported